A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969

Clinical trial NCT07581431 · RECRUITING

Trial details

NCT number: NCT07581431
Sponsor: InSilico Medicine Hong Kong Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects (HS)Obese Adult Participants at Risk of Cardiovascular Disease

Start date: 2026-06-15
Primary completion: 2027-01-29
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.